Business context and reporting period
CollPlant Biotechnologies Ltd. furnished this Form 6-K on October 6, 2026, covering the month of October 2026. The filing reports that the company issued a press release titled “LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations.” The press release itself is not included in the provided filing text.
Financial and operating results
The filing text provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics. It does not provide a clear description of the patent application or the platform’s technical or commercial details.
Material changes and outlook
No comparable-period results, financial guidance, outlook, or management commentary are provided in the filing text. The first two paragraphs of the press release are incorporated by reference into specified Form S-8 and Form F-3 registration statements.
Key facts to verify
- Review Exhibit 99.1 for the patent application’s scope, status, and any stated development or commercialization plans.
- Confirm whether the announcement identifies material costs, timelines, risks, or expected financial effects.
- Assess any implications for CollPlant separately from the LightSolver platform, as the filing text does not explain their relationship.